Marshall Wace, LLP Prestige Consumer Healthcare Inc. Transaction History

Marshall Wace, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$62.62 - $71.76 $481,923 - $552,264	7,696 Added 6.62%	123,920 $8.53 Million
Q1 2024 May 15, 2024	BUY	$58.76 - $75.07 $1.44 Million - $1.84 Million	24,474 Added 26.67%	116,224 $8.43 Million
Q4 2023 Feb 14, 2024	BUY	$57.0 - $61.94 $3.82 Million - $4.15 Million	66,941 Added 269.83%	91,750 $5.62 Million
Q3 2023 Nov 14, 2023	BUY	$56.7 - $68.29 $1.41 Million - $1.69 Million	24,809 New	24,809 $1.42 Million
Q2 2022 Aug 15, 2022	SELL	$52.06 - $58.9 $4.22 Million - $4.78 Million	-81,151 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$52.94 - $61.88 $4.3 Million - $5.02 Million	81,151 New	81,151 $4.3 Million
Q4 2020 Feb 16, 2021	SELL	$32.69 - $37.69 $1.24 Million - $1.43 Million	-38,058 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.54 - $40.79 $1.31 Million - $1.55 Million	38,058 New	38,058 $1.39 Million
Q2 2020 Aug 13, 2020	SELL	$36.63 - $44.07 $853,332 - $1.03 Million	-23,296 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$29.5 - $45.96 $687,232 - $1.07 Million	23,296 New	23,296 $854,000
Q2 2019 Aug 14, 2019	SELL	$27.65 - $31.68 $31,769 - $36,400	-1,149 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.28 - $41.29 $33,642 - $47,442	1,149 New	1,149 $35,000

334

50.3M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $3.82B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.